Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IMUX
#3021
Immunic, Inc. Common Stock
1.0
2
+10.87%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+10.87%
Aylık değişim
+61.90%
6 aylık değişim
+17.24%
Yıllık değişim
-8.93%
Önceki kapanış
0.9
2
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
2
Hacim
18
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
IMUX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
21.17 M
27.91 M
44.4 M
89.93 M
90.15 M
130.46 M
—
Valuation ratios
Enterprise value
196.21 M
180.21 M
-44.58 M
83.72 M
54.45 M
54.15 M
228.69 M
Price to earnings ratio
—
-2.44
-0.37
-0.69
-1
-0.86
-3.81
Price to sales ratio
—
52.25
9.36
122.88
3 339.16
—
—
Price to cash flow ratio
—
2.72
0.68
0.91
1.18
0.97
4.34
Price to book ratio
—
1.78
0.39
2.22
5.44
12.45
15.7
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.67
0.94
1.72
2.46
4.04
3.11
Return on equity %
0.28
0.73
1.06
3.24
5.45
14.56
10.94
Return on invested capital %
634.13
965.96
2 166.6
14.62 K
13.8 K
13.83 K
—
Gross margin %
100
100
100
100
100
200
800
Operating margin %
1 937.14
2 116
2 511.84
18.97 K
326.84 K
-20.77 K
-160.85 K
EBITDA margin %
—
—
—
—
—
20.94 K
161.39 K
Net margin %
1 741.18
2 145.54
2 531.15
17.9 K
335.02 K
-19.55 K
-155.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
15.93
9.21
9.62
2.12
1.77
0.75
4.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.03
0.04
0.01
0
-0.02
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.52
2.05
1.6
0.85
0.55
0.63
EBIT per share
—
—
—
—
—
-0.67
-0.76
EBITDA per share
—
—
—
—
—
-0.67
-0.76
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.67
3.66
1.05
0.36
0.1
0.84
Net current asset value per share
—
4.44
3.96
1.19
0.39
0.15
0.99
Tangible book value per share
—
3.98
3.57
0.65
0.18
0.04
0.41
Working capital per share
—
3.96
3.54
0.63
0.17
-0.05
0.18
Book value per share
—
5.37
3.57
0.65
0.18
0.04
0.41
Haberler
Immunic 200 milyon dolarlık finansmanı tamamladı, 200 milyon dolar daha alabilir
Immunic closes $200 million financing, may receive additional $200m
Why Is Immunic Stock Soaring Friday? - Immunic (NASDAQ:IMUX)
Immunic hisseleri 400 milyon dolarlık özel yerleşim anlaşması sonrası yükseldi
Immunic stock soars after $400 million private placement deal
Immunic secures up to $400 million in private placement financing
Immunic Stock Jumps After Pricing $400 Million Private Placement - Immunic (NASDAQ:IMUX)
2 ‘Strong Buy’ Stocks to Buy Today, 2/9/2026, According to Top Analysts - TipRanks.com
Immunic, MS ilacı hakkında ek verileri ACTRIMS forumunda sunacak
Immunic to present additional data on MS drug at ACTRIMS forum
Immunic, Nasdaq Global Select Market’ten Nasdaq Capital Market’e geçiyor
Immunic to transfer listing to Nasdaq Capital Market after bid price non-compliance